PAPER Cudkowicz, Rosas, Hayden
SEARCH RESULTS
268181 RESULTS
PAPER Travers J, Milgram S
An Experimental Study of the Small World Problem
Sociometry Vol. 32, No. 4 (Dec., 1969) .PAPER Cserr HF
Flow of Brain Interstitial Fluid and Drainage into Cerebrospinal Fluid and Lymph
In: Ishii S., Nagai H., Brock M. (eds) Intracranial Pressure V. Springer, Berlin, Heidelberg. (1983) .PAPER Paloneva J, Autti T, Hakola P, Haltia MJ
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL)
In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. SourceGeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. 2002 Jan 24 [updated 2015 Mar 12]. .PAPER Benzinger TL, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, Bateman R, Buckles V, the Dominantly Inherited Alzheimer Network (DIAN) Study Group
Tau PET Imaging With Av-1451 in Autosomal Dominant Alzheimer's Disease: Update from the Dominantly Inherited Alzheimer Network (DIAN)
Alzheimer's & Dementia, July 2016 .PAPER Fullerton T, Binneman B, David W, Delnomdedieu M, Kupjec J, Lockwood P, Mancuso J, Miceli J, Bell J
A Phase 2 Clinical Trial of Pf-05212377 (Sam-760) in Subjects With Mild to Moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Volume 12, Issue 7, .PAPER Qiu R, Liu R, Wills AM, He P, Leurent C, Hajos-Korcsok E, Mendes da Costa L, Alexander RC
PF-06648671–A Novel Gamma Secretase Modulator: Safety, Tolerability, Pharmacokinetics, and Effects on Plasma Amyloid-B Levels Following Single Oral Ascending Doses in Healthy Volunteers
July 2016, Volume 12, Issue 7, Supplement .PAPER de Wilde A, van der Flier WM, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, van Berckel BN, Scheltens P
The Diagnostic Value of Amyloid Pet in an Unselected Cohort of Memory Clinic Patients
Alzheimer's & Dementia, July 2016, Volume 12, Issue 7, Supplement .PAPER Zenaro E, Constantin G
Targeting neuaikroinflammation in the treatment and prevention of Alzheimer’s disease
Drugs of the Future 2017, 42(1): 21-42. .PAPER Leshner AI, Landis S, Stroud C, Downey A, Committee on Preventing Dementia and Cognitive Impairment; Board on Health Sciences Policy; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine
Preventing Cognitive Decline and Dementia: A Way Forward.
Washington (DC): National Academies Press (US); 2017 Jun. The National Academies Collection: Reports funded by National Institutes of Health. .PAPER Landen J
Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease
Alzheimer's & Dementia 8.4 (2012): P708. .PAPER Lasser R
Efficacy and safety of gantenerumab in prodromal Alzheimer’s disease: Results from scarlet road—a global, multicenter trial
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 11.7 (2015): P331-P332. .PAPER Blaettler T
Clinical trial design of CREAD: a randomized, double-blind, placebo-controlled, parallel-group Phase-3 study to evaluate crenezumab treatment in patients with prodromal-to-mild Alzheimer’s disease
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 12.7 (2016): P609. .PAPER Institute of Medicine (US) Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Liverman CT, Blazer DG
Testosterone and Aging: Clinical Research Directions
Washington (DC): National Academies Press (US); 2004. .PAPER Khan K
Heading for trouble: is dementia a game changer for football?
BJSM Blog, 15 Feb 2017 .Current Filters
- TYPE: Paper x